Abdominal Operations After Left Ventricular Assist Device Implantation and Heart Transplantation

被引:5
|
作者
Sanaiha, Yas [1 ]
Xing, Hanning [1 ]
Morales, Ricardo Rosales [1 ]
Morchi, Ravi [1 ,2 ]
Ragalie, William [1 ]
Benharash, Peyman [1 ]
机构
[1] Univ Calif Los Angeles, UCLA David Geffen Sch Med, Cardiovasc Outcomes Res Labs CORELAB, Div Cardiac Surg, Los Angeles, CA USA
[2] Univ Calif Orange, Dept Gen Surg, Orange, CA USA
关键词
Orthotopic heart transplantation; Left ventricular assist device; National inpatient sample; Abdominal complications; Emergency general surgery; GASTROINTESTINAL COMPLICATIONS; CARDIAC-SURGERY; NATIONAL TRENDS; CANDIDATES; MORTALITY; OUTCOMES; CARE; ERA;
D O I
10.1016/j.jss.2019.06.045
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Left ventricular assist devices (LVADs) are increasingly used to supplant the limited number of orthotopic heart transplantation (OHT). The present study aimed to perform a contemporary analysis of emergency abdominal operations after LVAD and OHT at a national level. Methods: The 2005-2015 National Impatient Sample, the largest all-payer hospitalization database in the United States, was used to identify all adult patients who had received LVAD or OHT. The primary outcome of interest was the rate of emergency general surgery (EGS), which included laparotomy, small or large bowel resection, peptic ulcer operation, adhesiolysis, and cholecystectomy, during the same hospitalization as LVAD or OHT. Logistic regression was used to determine risk factors for EGS as well as the association between EGS and mortality in both the LVAD and OHT populations. Results: Of the estimated 19,395 OHT and 23,441 LVAD performed, 445 (2.3%) OHT and 719 (3.1%) LVAD patients required EGS. The incidence of EGS in LVAD decreased from 5.4 to 3.3%, whereas it increased among OHT patients from 1.9 to 3.7%, P = 0.003. Occurrence of EGS after OHT and LVAD was associated with significantly higher inpatient risk-adjusted mortality (OHT adjusted odds ratio, 3.0; P = 0.004; LVAD adjusted odds ratio, 2.5; P < 0.001), incremental hospitalization costs (OHT, $ 106,778; P < 0.001; LVAD, $ 61,965; P < 0.001), and length of stay (OHT, 27.9 d; P < 0.001; LVAD, 20.8 d; P < 0.001). Conclusions: EGS remains an infrequent but high mortality and cost complication of OHT and LVAD. Further investigation of the impact of immunosuppression, anticoagulation, and perfusion strategies on incidence of abdominal complications is warranted. (C) 2019 Published by Elsevier Inc.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 50 条
  • [31] Longitudinal Heart Failure Medication Use and Adherence Following Left Ventricular Assist Device Implantation in Privately Insured Patients
    Tan, Nicholas Y.
    Sangaralingham, Lindsey R.
    Schilz, Stephanie R.
    Dunlay, Shannon M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (10):
  • [32] Caregiver status and outcomes after durable left ventricular assist device implantation
    Koeckert, Michael
    Vining, Patrick
    Reyentovich, Alex
    Katz, Stuart D.
    DeAnda, Abe, Jr.
    Philipson, Stefanie
    Balsam, Leora B.
    HEART & LUNG, 2017, 46 (02): : 74 - 78
  • [33] A Bayesian Model to Predict Survival After Left Ventricular Assist Device Implantation
    Kanwar, Manreet K.
    Lohmueller, Lisa C.
    Kormos, Robert L.
    Teuteberg, Jeffrey J.
    Rogers, Joseph G.
    Lindenfeld, JoAnn
    Bailey, Stephen H.
    McIlvennan, Colleen K.
    Benza, Raymond
    Murali, Srinivas
    Antaki, James
    JACC-HEART FAILURE, 2018, 6 (09) : 771 - 779
  • [34] Impact of Previous Sternotomy on Outcome after Left Ventricular Assist Device Implantation
    Zhigalov, Konstantin
    Szczechowicz, Marcin
    Mashhour, Ahmed
    Mkalaluh, Sabreen
    Isaev, Maxim
    Kadyraliev, Bakitbek
    Easo, Jerry
    Ennker, Juergen
    Eichstaedt, Harald
    Weymann, Alexander
    THORACIC AND CARDIOVASCULAR SURGEON, 2019, 67 (03) : 183 - 190
  • [35] The impact of extreme obesity on outcomes after left ventricular assist device implantation
    Yost, Gardner
    Coyle, Laura
    Gallagher, Colleen
    Graney, Nicole
    Siemeck, Roxanne
    Tatooles, Antone
    Pappas, Patroklos
    Bhat, Geetha
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4441 - 4446
  • [36] Recent Changes in Durable Left Ventricular Assist Device Bridging to Heart Transplantation
    Srinivasan, Amudan J.
    Seese, Laura
    Mathier, Michael A.
    Hickey, Gavin
    Lui, Cecillia
    Kilic, Arman
    ASAIO JOURNAL, 2022, 68 (02) : 197 - 204
  • [37] The Association of Pretransplant HeartMate II Left Ventricular Assist Device Placement and Heart Transplantation Mortality
    Donneyong, Macarius
    Cheng, Allen
    Trivedi, Jaimin R.
    Schumer, Erin
    McCants, Kelly C.
    Birks, Emma J.
    Slaughter, Mark S.
    ASAIO JOURNAL, 2014, 60 (03) : 294 - 299
  • [38] Right ventricular failure after left ventricular assist device implantation:: The need for an implantable right ventricular assist device
    Furukawa, K
    Motomura, T
    Nosé, Y
    ARTIFICIAL ORGANS, 2005, 29 (05) : 369 - 377
  • [39] Right heart failure post left ventricular assist device implantation
    Argiriou, Mihalis
    Kolokotron, Styliani-Maria
    Sakellaridis, Timothy
    Argiriou, Orestis
    Charitos, Christos
    Zarogoulidis, Paul
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Machairiotis, Nikolaos
    Tsiouda, Theodora
    Tsakiridis, Kosmas
    Zarogoulidis, Konstantinos
    JOURNAL OF THORACIC DISEASE, 2014, 6 : S52 - S59
  • [40] Days alive and out of hospital after left ventricular assist device implantation
    Roth, Sebastian
    M'Pembele, Rene
    Stroda, Alexandra
    Voit, Josephine
    Buse, Giovanna Lurati
    Sixt, Stephan U.
    Westenfeld, Ralf
    Polzin, Amin
    Rellecke, Philipp
    Tudorache, Igor
    Hollmann, Markus W.
    Boeken, Udo
    Akhyari, Payam
    Lichtenberg, Artur
    Huhn, Ragnar
    Aubin, Hug
    ESC HEART FAILURE, 2022, 9 (04): : 2455 - 2463